Brief: Maia Biotech Inc Announces Research Collaboration With Nationwide Children's Hospital
14/06/2022 13:30
June 14 (Reuters) - Maia Biotechnology Inc MAIA.O :
* MAIA BIOTECHNOLOGY, INC. ANNOUNCES RESEARCH COLLABORATION
WITH
NATIONWIDE CHILDREN'S HOSPITAL TO EVALUATE THIO IN COMBINATION
WITH STANDARD-OF-CARE CANCER THERAPIES
Source text for Eikon: ID:nBw4h81yka
Further company coverage: MAIA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Maia Biotechnology
See all newsBrief: Maia Biotechnology Says Ateganosine Plus Cemiplimab Outperforms Standard Chemotherapy Dcr In 3l Nsclc
Brief: Maia Biotechnology - To Terminate At The Market Offering Agreement Effective May 23, 2026 - SEC Filing
Brief: Maia Biotechnology Reports Overall Survival Exceeding Two Years For Eight Patients In Ongoing Phase 2 Clinical Trial In Non-Small Cell Lung Cancer
Brief: Maia Biotechnology Inc Enters Underwriting Agreement With Konik Capital Partners - SEC Filing
MAIA Biotechnology plunges after $30 million share sale